MedCity News

Judi Health Taps Color Health, WellTheory, Cylinder for Clinical Ecosystem

7 Hospital Mergers from Summer 2026

A roundup of the seven most notable hospital mergers and acquisitions announced or completed this summer, including Prisma Health’s acquisition of Erlanger Health and Sanford Health’s purchase of North Memorial Health

By Katie Adams

BioPharma, Pharma

Ultragenyx Trial Failure Revives Debate About How to Treat a Rare Neuro Disorder

Ultragenyx Pharmaceuticals’ apazunersen did not meet the goals of its Phase 3 test in Angelman syndrome, a rare genetic neurological disorder with no FDA-approved therapies. The disappointing result has some readthrough to Ionis Pharmaceuticals and Oak Hill Bio, each in clinical development with Angelman drugs designed to work in a similar way as Ultragenyx’s failed molecule.

By Frank Vinluan

Latest Video

Latest News

MedCity Influencers

Healing Through Heritage: Why Culturally Grounded Recovery Matters on Tribal Lands

This shift is not about replacing clinical care with tradition. It is about recognizing that healing in Native communities has always been deeply connected to culture.

By Selena Stockley

Devices & Diagnostics

3D computed tomography (CT) scan of the chest of a 60 year old male patient with a pneumothorax, or collapsed lung. The right lung (seen on the left) has collapsed due to a build-up of air between the lung and chest wall. Pneumothorax can be due to trauma or lung rupture. It causes shortness of breath and pain on breathing. It is treated by inserting a tube to drain the air over a period of days, allowing the lung to re-inflate

This Device Could Prevent Lung Biopsy’s Most Common — and Costly — Complication

Selio Medical developed an FDA-cleared hydrogel device that seals CT-guided lung biopsy punctures before they can cause pneumothorax — a collapsed lung complication that affects up to a third of the 800,000+ such biopsies performed annually in the U.S.

By Katie Adams

Health Tech

Thyme Care Raises $125M, Launches New Oncology Parent Entity

Thyme Care's Series E round was led by Morgan Health and included participation from Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures and a16z Bio + Health.

By Marissa Plescia

BioPharma, Pharma

Teva Drug Rises to the Gluten Challenge, Stopping Intestinal Damage in Celiac Disease Trial

In a mid-stage study, Teva’s drug prevented intestinal damage in celiac disease patients who underwent a gluten challenge — eating food with gluten to see if it prompts an immune response. There are currently no FDA-approved drugs for celiac disease, but Teva’s antibody is part of a competitive race to bring patients the first one.

By Frank Vinluan

MedCity Influencers

Why Pharma Companies Should Look To Social Media For Better Patient Insight

Healthcare decision-makers, especially at pharmaceutical companies, must prioritize patient input. Data collected from social media listening is a significant step in the right direction.

By Rohit Marwah

MedCity Influencers

Artificial intelligence in medicine. Doctor character uses ai app for patient diagnosis, medical analysis. Healthcare technology concept. Vector illustration.

The Healthcare Inflection Point: AI Can’t Fix 1990s Technology

Isolated improvements rarely translate into enterprise-wide transformation when they are layered onto outdated, inefficient workflows instead of being integrated into redesigned care delivery.

By Richard Atkin

Consumer / Employer, Policy

HHS Provides $77M in Grants for Substance Use Prevention, Mental Health

HHS awarded $77 million in SAMHSA grants for substance use prevention and treatment, mental health, suicide prevention and crisis services.

By Marissa Plescia

BioPharma, Pharma

GSK’s Pivotal Test for mRNA Flu Vaccine Aims to Show Two Targets Are Better Than One

GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of the virus. That could be an advantage over Moderna’s recently approved mRNA flu shot, which addresses just one of those proteins.

By Frank Vinluan

MedCity Influencers

Breaking the Amendment Cycle: How Agentic AI Enables Smarter Clinical Trial Design and Operations

Faster trials are not a vanity metric. They reflect an undeniable need: getting safe therapies to patients sooner.

By Eron Kelly

Artificial Intelligence, Startups, Health Tech, Payers, Providers

Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs

August has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Humana, Merck and Mayo Clinic named new executives. There were also layoffs at organizations including MaineHealth, Cellares and Sharp HealthCare.

By Katie Adams

Providers

MedCity FemFwd: How Midwives Can Support the Maternal Health Crisis

In this episode, we’re joined by Amanda Shafton, practicing CNM and national director of midwifery at Ob Hospitalist Group. We discuss the benefits of physician/midwifery collaboration and how midwives can improve maternal health outcomes.

By Marissa Plescia

Health Tech

Little pink ceramic piggy bank pattern on the left side on yellow background. Concept of saving money, savings.

4 Notable Health Tech Funding Announcements in August

Health tech companies made several major funding announcements in August. Here is a list of some of the biggest funding rounds.

By Marissa Plescia

BioPharma, Pharma

First-in-Class Takeda, Protagonist Drug Lands FDA Approval in Rare Blood Disorder

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic options. Originally developed by Protagonist Therapeutics, the engineered peptide gives Takeda a drug with blockbuster sales potential as the pharma company’s top overall product faces patent expirations.

By Frank Vinluan

MedCity Influencers

AI Won’t Transform Health Systems, CEOs Will — 6 Principles to Drive the Transformation

If AI is not one of the CEO’s top two or three priorities, the organization will produce pilots and slide decks while better-mobilized peers pull ahead and the institution’s ability to fulfill its mission erodes

By Marc Harrison

Artificial Intelligence, Health Tech, Providers

Doctors and the Virtual Medical Revolution and Technological Advances Artificial Intelligence (AI) Deep Learning for Medical Research and Future Health Technology

Hospitals Are All In on AI, but Testing and Oversight Haven’t Caught Up

A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the infrastructure to properly test and validate them before they become embedded in patient care.

By Katie Adams